Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a robotic exoskeleton rebuild aging legs?

NCT ID NCT07830472

NEW Symptom relief Sponsor: Taipei Medical University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Researchers are testing whether lower-limb rehabilitation robot training, added to nutrition education, can improve muscle mass and physical function in adults aged 60 and older with sarcopenia, the age-related loss of muscle. Participants receive either eight weeks of robot-assisted training on the MRG-P110 device plus nutrition education, or usual care that includes exercise and nutrition education. The study measures changes in muscle mass, handgrip strength, walking speed, balance, and quality of life to see whether the robot approach offers extra benefit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
lower-limb rehabilitation robot training using the MRG-P110 device, combined with nutrition education
What this could lead to
If it works, robot-assisted training could become an added option for older adults with sarcopenia who want to rebuild leg strength and walking ability beyond standard exercise.
What could go wrong
This is a small, 40-person study, so any benefits may be modest or may not hold up in larger groups. Robot training also requires fitting into the device, and some participants may find the sessions uncomfortable or hard to tolerate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 60 years or older. * Meets the diagnostic criteria for sarcopenia according to the Asian Working Group for Sarcopenia (AWGS). * Conscious and able to understand and follow movement instructions. * Able to stand for at least 1 minute. * Physically able to tolerate lower-limb rehabilitation robot training. Exclusion Criteria: * Body weight greater than 135 kg. * Height less than 145 cm or greater than 190 cm, resulting in incompatibility with the exoskeleton. * Presence of an unhealed fracture. * Joint contracture or excessive lower-limb muscle tone that prevents participation in robotic training.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sarcopenia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sarcopenia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Taipei Medical University Hospital

    RECRUITING

    Taipei, Taipei City, 11031, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.